Search
Now showing items 1-8 of 8
Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry.
(Clin Cardiol, 2016-02)
BACKGROUND: Patients with sinus node dysfunction (SND) have increased risk of atrial
tachyarrhythmias, including atrial fibrillation (AF). To date, treatment patterns
and outcomes of patients with SND and AF have not been ...
Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry.
(J Am Heart Assoc, 2013-07-18)
BACKGROUND: The prevalence of atrial fibrillation (AF) continues to increase; however,
there are limited data describing the division of care among practitioners in the
community and whether care differs depending on provider ...
Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
(Circulation, 2015-02-03)
BACKGROUND: Temporary interruption of oral anticoagulation for procedures is often
required, and some propose using bridging anticoagulation. However, the use and outcomes
of bridging during oral anticoagulation interruptions ...
Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital Revascularization.
(J Am Heart Assoc, 2016-03-14)
BACKGROUND: While use of P2Y12 receptor inhibitor is recommended by guidelines, few
studies have examined its effectiveness among older non-ST-segment elevation myocardial
infarction patients who did not undergo coronary ...
Heart rate is associated with progression of atrial fibrillation, independent of rhythm.
(Heart, 2015-06)
OBJECTIVE: Atrial fibrillation (AF) often progresses from paroxysmal or persistent
to more sustained forms, but the rate and predictors of AF progression in clinical
practice are not well described. METHODS: Using the Outcomes ...
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation.
(J Am Heart Assoc, 2013-11-25)
BACKGROUND: Dabigatran is a novel oral anticoagulant approved for thromboprophylaxis
in atrial fibrillation. Adoption patterns of this new agent in community practice
are unknown. METHODS AND RESULTS: We studied patterns ...
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
(Eur Heart J, 2015-12-07)
BACKGROUND: Therapeutic decisions in atrial fibrillation (AF) are often influenced
by assessment of bleeding risk. However, existing bleeding risk scores have limitations.
OBJECTIVES: We sought to develop and validate a ...
Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF).
(J Am Heart Assoc, 2015-09-14)
BACKGROUND: Most patients with atrial fibrillation (AF) require rate control; however,
the optimal target heart rate remains under debate. We aimed to assess rate control
and subsequent outcomes among patients with permanent ...